Natural Product: NPC69670

Natural Product IDNPC69670
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Methyl (2E,4E,8E)-9-(1,3-Benzodioxol-5-Yl)Nona-2,4,8-Trienoate
IUPAC Name methyl (2E,4E,8E)-9-(1,3-benzodioxol-5-yl)nona-2,4,8-trienoate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2414113
PubChem CID 10827065
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000296] Benzodioxoles

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HLJZJOPIVFTQNX-NFGBADIGSA-N
Standard InCHI InChI=1S/C17H18O4/c1-19-17(18)9-7-5-3-2-4-6-8-14-10-11-15-16(12-14)21-13-20-15/h3,5-12H,2,4,13H2,1H3/b5-3+,8-6+,9-7+
SMILES COC(=O)/C=C/C=C/CC/C=C/c1ccc2c(c1)OCO2

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   286.12 Volume:   302.181
?
Van der Waals volume.
Dense:   0.947 LogP:   3.615
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.101
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.994
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   14.0
TPSA:   44.76
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   0.0 Rings:   2.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.347 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.662 Fsp3:   0.235
MCE-18:   20.952
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.787 Fluc inhibitor:   0.999
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.659
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.793
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.939 Promiscuous compounds:   0.314

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.846 MDCK Permeability:   -4.635
Pgp-inhibitor:   0.983 Pgp-substrate:   0.001
PAMPA:   0.006
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.484 30% Bioavailability (F30%):   0.228
50% Bioavailability (F50%):   0.915

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.002
Plasma Protein Binding (PPB):   98.858% Volume Distribution (VD):   -0.373
Fu: 0.738%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.986
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.537
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.827 CYP1A2-substrate:   1.0
CYP2C19-inhibitor:   0.044 CYP2C19-substrate:   0.923
CYP2C9-inhibitor:   0.522 CYP2C9-substrate:   1.0
CYP2D6-inhibitor:   0.999 CYP2D6-substrate:   0.998
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.001 CYP2C8-inhibitor:   1.0
HLM stability:   0.845
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.233 Half-life (T1/2):  0.835

ADMET: Toxicity

hERG Blockers:  0.412 hERG Blockers (10um):  0.635
Human Hepatotoxicity (H-HT):  0.719 Drug-induced Liver Injury (DILI):  0.598
AMES Toxicity:  0.778 Rat Oral Acute Toxicity:  0.222
Maximum Recommended Daily Dose:  0.843 Skin Sensitization:  0.947
Carcinogencity:  0.409 Eye Corrosion:  0.041
Eye Irritation:  0.745 Respiratory Toxicity:  0.556
Drug-induced Neurotoxicity:  0.364 Ototoxicity:  0.421
Hematotoxicity:  0.319 Drug-induced Nephrotoxicity:  0.601
Genotoxicity:  0.275 RPMI-8226 Immunitoxicity:  0.089
A549 Cytotoxicity:  0.122 Hek293 Cytotoxicity:  0.531
BCF:   1.582
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.204
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.037
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.343
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19004 Dryobalanops camphora Species Dipterocarpaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO19078 Lophocolea bidentata Species Lophocoleaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO19004 Dryobalanops camphora Species Dipterocarpaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO19078 Lophocolea bidentata Species Lophocoleaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT520 Cell line 3T3-L1 Mus musculus Activity = 4.0 % PMID[23910984]
NPT520 Cell line 3T3-L1 Mus musculus Activity = 4.6 % PMID[23910984]
NPT520 Cell line 3T3-L1 Mus musculus Activity = -4.6 % PMID[23910984]
NPT520 Cell line 3T3-L1 Mus musculus Activity = -2.9 % PMID[23910984]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC69670 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7963 Intermediate Similarity NPC114845
0.7347 Intermediate Similarity NPC199209
0.6271 Remote Similarity NPC103947
0.6271 Remote Similarity NPC45783
0.62 Remote Similarity NPC212643
0.6167 Remote Similarity NPC73883
0.6167 Remote Similarity NPC251454
0.5873 Remote Similarity NPC170583
0.5763 Remote Similarity NPC159150
0.5645 Remote Similarity NPC328419
0.5556 Remote Similarity NPC220923
0.5556 Remote Similarity NPC196609
0.5306 Remote Similarity NPC127326
0.5303 Remote Similarity NPC71105
0.5224 Remote Similarity NPC41331
0.5224 Remote Similarity NPC291449
0.5161 Remote Similarity NPC193673
0.5098 Remote Similarity NPC111225
0.5079 Remote Similarity NPC230698
0.5079 Remote Similarity NPC99078
0.5079 Remote Similarity NPC96406
0.5079 Remote Similarity NPC318862

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC69670 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data